2022 highlights in interventional cardiology Novel concepts for multivessel coronary artery disease treatment, vascular access for coronary interventions, and heart valve interventions
Main Article Content
Keywords
Highlights, left ventricular dysfunction, left main, multivessel coronary disease, femoral access, mitral regurgitation, TAVI, cerebral embolic protection, fractional flow reserve, BEST trial, UNIVERSAL trial, REVIVED-BCIS2 trial, FAME 3 trial, CLASP IID trial, PROTECTED TAVR trial, TAVR
Abstract
In 2022 much new evidence-based information related to coronary and structural interventions has been published, and several trials offered new therapies and practice-changing insights for patients with advanced ischemic and structural heart disease. Therefore, this review highlights some of the most stimulating data from the latest published manuscripts in the interventional cardiology field.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
To know more about License Terms see Publication Ethics.